BiomX’s mid-stage cystic fibrosis trial put on clinical hold; Santen makes a deal with RemeGen

Plus, news about Opthea, Greenwich and iBio: FDA puts clinical hold on BiomX’s Phase 2b trial in cystic fibrosis: The company is testing BX004, its multi-phase treatment candidate, in CF patients ...